{"id":"W1989944891","doi":"10.1517/14712598.8.7.1011","title":"Adalimumab for the treatment of Crohn's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Crohn's disease; Monoclonal antibody; Disease; Monoclonal; Internal medicine; Inflammatory bowel disease; Clinical trial; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006941374,0.001231192,0.001587891,0.001940845,0.0003469902,0.0008574013,0.001097963,0.001686051,0.006684981],"category_scores_gemma":[0.0006591072,0.0002765336,0.0006423548,0.001627196,0.0004839561,0.001060005,0.000702626,0.003054706,0.008992739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000682836,"about_ca_system_score_gemma":0.0007735949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000906295,"about_ca_topic_score_gemma":0.001900288,"domain_scores_codex":[0.999689,0.00005896291,0.00003624841,0.00004734804,0.0001414823,0.00002707697],"domain_scores_gemma":[0.999757,0.00007594007,0.00004538517,0.000009631632,0.00007669877,0.0000352725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001291082,0.00008104912,0.00008475401,0.006812509,0.00009045348,0.0002478838,0.00003261515,0.000168644,0.001385492,0.001702082,0.07654942,0.9127159],"study_design_scores_gemma":[0.00007488272,0.00006763721,0.0003372677,0.001195266,0.0000617629,0.001373725,0.00001489758,0.00005224471,0.0002160289,0.0008748617,0.9957211,0.00001028347],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000881439,0.995702,0.0001647056,0.0005394141,0.0009659217,0.00001112043,0.00001991981,0.00001427372,0.002494398],"genre_scores_gemma":[0.001016007,0.993049,0.0004433523,0.001116867,0.0008863813,0.00001949958,0.00007344424,0.000004117278,0.003391309],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006684981,"threshold_uncertainty_score":0.02236354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.116582758874184,"score_gpt":0.3832660486252241,"score_spread":0.2666832897510401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}